v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues:    
Net product sales $ 34,711 $ 38,903
Cost of product sales 10,638 8,457
Gross profit 24,073 30,446
Operating expenses:    
Research and development 2,385 2,279
General and administrative 12,145 12,702
Sales and marketing 14,308 12,311
Total operating expenses 28,838 27,292
(Loss) income from operations (4,765) 3,154
Other expense, net (3,346) (519)
Net (loss) income (8,111) 2,635
Other comprehensive (loss) income:    
Unrealized loss on short-term investments (10) (12)
Comprehensive (loss) income $ (8,121) $ 2,623
Basic net (loss) income per share $ (0.04) $ 0.02
Diluted net (loss) income per share $ (0.04) $ 0.01
Net income, shares 189,646 153,490
Weighted average common shares outstanding, diluted 189,646 196,921